-
Patent Issued for Crispr-Edited Viruses in Microbiome
A biotechnology company developing gene-edited therapies for bacterial infections in the gut received a U.S. patent for viruses engineered as treatments.
-
Infographic – Biotech Index Q3 Rollercoaster
For the year-to-date, as noted in today’s chart, NBI shows a general decline, losing more than one-fifth of its value since January.
-
Start-Up Developing Efficient RNA Process, Raises $12M
A company formed earlier this year is commercializing a more efficient process for making synthetic RNA molecules and raising $12 million in seed funds.
-
Stem Cell Lab Planned for Commercial Space Station
A collaboration between university researchers and a space science company is designing a stem cell research lab on a proposed commercial space station.
-
Company Formed to Boost Clinical Trial Success Odds
A pharma/tech industry group is starting a new company to use algorithms for finding gaps in preclinical data that can impair clinical trial progress.
-
Start-Up Licenses Gene-Edited Drug Discovery Tech.
A new company is acquiring a technology using genome-edited tadpoles that finds current drugs addressing precise genetic conditions underlying rare diseases.
-
Rosh Hashanah 5783
Science and Enterprise is taking off today to observe Rosh Hashanah, the Jewish new year.
-
Infographic – Earth Orbits Getting More Crowded
The rate of new earth-orbit launches is accelerating, with OECD expecting tens of thousands of new satellites launched in the next five years.
-
NIH Funds Decentralized Rare Disease Data Network
A start-up company is building a secure decentralized network of genomic and other medical data on rare diseases, funded by a fast-track award from an NIH agency.
-
FDA Clearance Requested for Behavioral Diabetes Therapy
A digital health company is asking for FDA authorization to market a mobile app that helps treat type 2 diabetes with cognitive behavioral therapy.